From March 11 to 14, i-SENS participated in the Advanced Technologies & Treatments for Diabetes 2026 (ATTD 2026) held in Barcelona, Spain, where we successfully showcased our products alongside a series of in-booth presentations and hands-on experience workshops.
Showcasing Innovation with CareSens Air 2
At this year’s exhibition, i-SENS introduced a dedicated zone where visitors could preview our next-generation CGMS(Continuous Glucose Monitoring System), CareSens Air 2. The space highlighted its enhanced performance and innovation compared to the current CareSens Air, attracting strong interest from attendees.
Engaging Healthcare Professionals Through In-Booth Sessions
A total of three in-booth sessions were conducted during ATTD 2026. The “What’s NEXT in CareSens Air” introduced i-SENS’s robust R&D capabilities built on its manufacturing expertise in Korea, while outlining the background, vision, and future direction behind CareSens Air 2.
The “CareSens Air Across Expanding CGM Guidelines, Clinical Evidence, and Real-World Practice” targeted clinicians currently using or considering the adoption of CareSens Air, providing practical insights into how our solutions can support clinical decision-making and patient management.
Lastly, we also hosted a “CareSens Air Hands-On Workshop,” where approximately 40 pre-registered participants had the opportunity to experience key features of the system. The program included sensor application, connecting sensor to app, and an introduction to the Sens365 platform, allowing participants to better understand the product in a real-world context.
Strengthening Global Engagement in Diabetes Care
Through ATTD 2026, i-SENS connected with healthcare professionals and industry stakeholders from around the world, sharing meaningful innovations in diabetes management. We sincerely thank all visitors who joined us at our booth and look forward to connecting again in the coming year.